MedTrace Logo

Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People

NCT05728918 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2024-08-09

No results posted yet for this study

Summary

This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people.

Conditions

  • Fatigue Syndrome, Chronic
  • Cold

Interventions

DIETARY_SUPPLEMENT

Antrodia cinnamomea mycelia

Antrodia cinnamomea mycelia capsule, two capsules/day (600 mg/day) for 3 months

DIETARY_SUPPLEMENT

Placebo

Placebo capsule, two capsules/day (600 mg/day) for 3 months

Sponsors & Collaborators

  • Greenyn Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Ming-Shun Wu, MD · WanFang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-02-29
Completion
2024-05-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05728918 on ClinicalTrials.gov